PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
About PTC Clinical Trials Careers at PTC
PTC Therapeutics To Present At The 33rd Annual J.p. Morgan Healthcare Conference
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Begins Rolling Nda Submission To The Fda For Translarna To Treat Duchenne Muscular Dystrophy
View all latest news